SIRT1 and metabolic dysfunction-associated steatotic liver disease: In the liver, SIRT1 enhances fatty acid oxidation while inhibiting synthesis, crucial for preventing fat accumulation and MASLD progression (Ryall et al., 2015; Wątroba et al., 2023).